Amgen, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing

Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries

CEO Name:
Robert Bradway
Executive Director

Contact
KS
Kathy Sherman
601 13th Street, NW, Suite 1100 North
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Kevin Johnson Exclusive Duties No Authorized On 12/17/2018 Withdrawn On N/A
Matt Phillips Exclusive Duties No Authorized On 12/17/2018 Withdrawn On 12/21/2018
Scott Stenger Exclusive Duties No Authorized On 12/17/2018 Withdrawn On 12/21/2018

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 24
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

For
Notification Date
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

2019 Wisconsin Act 12

For
Notification Date
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Substitution of interchangeable biosimilars
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/14/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
Total Lobbying Expenditures 2019
January - June
$894.24
2019
July - December
$0.00
2020
January - June
$0.00
2020
July - December
$0.00
Total $894.24
Total Hours Communicating 2019
January - June
1.00
2019
July - December
0.00
2020
January - June
0.00
2020
July - December
0.00
Total 1.00
Total Hours Other 2019
January - June
11.00
2019
July - December
0.00
2020
January - June
0.00
2020
July - December
0.00
Total 11.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
45 %
2019
July - December
2020
January - June
2020
July - December
Total 42 %
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
45 %
2019
July - December
2020
January - June
2020
July - December
Total 42 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10 %
2019
July - December
2020
January - June
2020
July - December
Total 10 %

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
100 %
2020
January - June
100 %
2020
July - December
100 %
Total < 1%

Filed Statements of Lobbying Activity and Expenditures